Eventually, the overall ability of DYRK1B to slow proliferation as well as to foster survival might be one reason why this kinase has previously been linked to cancer stem cells and stem cell-enriched tumor spheroids [93–95]. The gene discussed is DYRK1B; the disease is neoplasm.